Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
305.22 221.42 174.42 178.27 364.30 621.38 657.45 92.15 88.56 215.46
Receivables
64.85 82.16 80.95 117.25 122.35 114.04 115.46 129.12 81.89 46.75
Inventory
1.08 0.74 (0.81) 0.65 0.65 — — — — —
Other current assets
9.03 7.00 11.00 11.00 9.00 1.12 8.00 — — —
Total current assets
380.18 311.60 266.44 306.85 495.84 745.23 780.63 233.29 182.37 274.18
Property, Plant, Equpment (Net)
20.51 17.27 7.65 12.43 8.93 7.58 6.29 5.59 4.50 3.41
Long-term receivables
— — — 32.60 23.40 24.00 14.59 — — —
Goodwill and Intangible Assets (Total)
166.90 160.69 0.79 1.00 — — — 3.68 2.86 2.04
Long Term Assets (Tax, Deferred)
— — — — — 333.29 283.66 212.32 144.23 103.43
Long-term assets (Other)
142.22 116.11 47.54 33.13 14.49 1.49 1.33 3.61 5.92 4.50
Total non-current assets
329.64 294.08 65.62 95.90 63.40 381.70 319.89 237.79 168.54 122.72
Total Assets
709.82 605.67 332.05 402.75 559.24 1,126.93 1,100.52 471.07 350.91 396.90
Accounts Payable
17.70 15.96 14.89 5.49 0.66 0.94 0.48 7.83 2.13 2.90
Accrued Expenses
45.24 45.55 40.96 33.42 28.38 39.46 21.96 65.59 33.53 36.39
Current Part of Debt
6.23 4.00 47.55 1.00 3.00 116.86 3.00 199.56 — 199.68
Current Part of Capital Lease
6.23 4.08 0.07 — — — — — — —
Current Revenue (Deferred)
7.72 0.20 0.25 0.88 0.00 — — — — —
Other current liabilities
14.24 0.25 0.05 34.00 28.00 1.32 0.02 — — —
Total current liabilities
91.13 66.03 119.52 40.93 32.17 161.70 25.53 276.10 38.85 242.22
Long Term Debt (Total)
366.57 396.09 366.30 407.99 430.26 356.00 396.25 498.31 583.99 385.00
Non-current Revenue (Deferred)
0.56 5.45 6.31 — — — — — — —
Non-current Liabilities (Other)
184.84 128.26 36.29 24.99 13.85 340.83 9.77 28.42 17.11 21.65
Total non-current liabilities
551.97 529.80 408.90 455.07 464.43 359.32 422.62 541.27 613.40 416.52
Total liabilities
643.11 595.83 528.42 496.00 496.60 521.02 448.14 817.37 652.24 658.74
Additional Paid In Capital
1,258.40 1,318.54 1,394.60 1,478.82 1,528.54 1,543.36 1,348.60 1,355.20 1,395.32 1,412.78
Common Stock (Net)
0.15 0.15 0.15 0.16 0.16 0.16 0.15 0.16 0.16 0.16
Retained Earnings
(1,191.82) (1,308.76) (1,591.13) (1,572.23) (1,466.06) (937.61) (696.38) (1,698.61) (1,697.73) (1,673.72)
Common Equity (Total)
66.72 9.85 (196.37) (93.25) 62.64 605.91 652.38 (346.29) (301.33) (261.83)
Shareholders Equity (Total)
66.72 9.85 (196.37) (93.25) 62.64 605.91 652.38 (346.29) (301.33) (261.83)
Shareholders Equity and Liabilities (Total)
709.82 605.67 332.05 402.75 559.24 1,126.93 1,100.52 471.07 350.91 396.90
Shares (Common)
147.12 150.45 154.42 157.54 160.62 162.04 154.03 156.35 160.21 163.06
Shareholders Equity (Tangible)
(100.19) (150.84) (197.16) (93.25) 62.64 605.91 652.38 (349.98) (304.19) (263.87)
Net Debt
67.59 178.68 239.43 230.72 68.96 (148.52) (258.20) 605.72 495.43 369.22
Total Debt
372.80 400.09 413.85 408.99 433.26 472.86 399.25 697.87 583.99 584.68

Fold the line items

In millions of $ except per-share values · columns are period end dates